Curetis GmbH develops, produces and markets molecular diagnostic products and solutions to combat infectious diseases; these include the Unyvero instrument platform and five CE-marked single-use cartridges for different indications. The company also markets a CE-marked PCR-based SARS‑CoV‑2 test kit and provides local test services. The company is headquartered in Holzgerlingen with cartridge production in Bodelshausen; sole shareholder is Crystal GmbH and since April 1, 2020 OpGen, Inc. is the ultimate parent company. Through its 100% subsidiary Ares Genetics, Curetis holds the GEAR database of genetic data on antibiotic resistances, which the report identifies as a significant future value driver.
Entwicklung, Produktion und Vermarktung von Produkten und Lösungen zur Bekämpfung von Infektionskrankheiten
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 756134 (as of 27 May 2026)
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 756134 (as of 27 May 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Stuttgart Local Court, HRB 756134 (as of 27 May 2026)
Sign in to view detailed salary and cost trends.
